2021, 374:472-478. 
13. Wang P, et al.: Antibody resistance of SARS-CoV-2 variants B. 
1.351 and B.1.1.7. Nature 2021, 593:130-135. 
14. Graham C, et al.: Neutralization potency of monoclonal 
antibodies recognizing dominant and subdominant epitopes on 
SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Immunity 
2021, 54:e1276. 
15. Andreano E, et al.: Anatomy of Omicron BA. 1 and BA. 2 
neutralizing antibodies in COVID-19 mRNA vaccinees. Nat 
Commun 2022, 13:1-8. 
16.
â€¢
Xu S, et al.: Mapping cross-variant neutralizing sites on the 
SARS-CoV-2 spike protein. Emerg Microbes Infect 2022, 
11:351-367. 
This paper reported a relatively strong broadly neutralizing mAb tar -
geting the SD1 region of SARS-CoV-2 spike. 
17. Hurlburt NK, et al.: Structural definition of a pan-sarbecovirus 
neutralizing epitope on the spike S2 subunit. Commun Biol 
2022, 5:1-13. 
18. Dacon C, et al.: Broadly neutralizing antibodies target the 
coronavirus fusion peptide. Science 2022, 377:728-735.